Z-2937-2026 Class II Ongoing

Recalled by Bioporto Diagnostics A/S — Hellerup

FDA device recall Z-2937-2026 was initiated by Bioporto Diagnostics A/S on May 18, 2026 and is designated Class II. Reason for recall: The use of a non-validated rework process for assay reagents which could lead to missed diagnosis of renal disease, inappropriate treatment decisions, or inappropriate monitoring of renal disease in… The recall status is ongoing. Affected quantity: 400 units.

Recall details

Product Type
Devices
Report Date
Aug 19, 2026
Initiation Date
May 18, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
400 units

Product description

ProNephro AKI (NGAL) Reagent Kit (100 tests). IVD Acute Kidney Injury Test System.

Reason for recall

The use of a non-validated rework process for assay reagents which could lead to missed diagnosis of renal disease, inappropriate treatment decisions, or inappropriate monitoring of renal disease in intended users.

Distribution pattern

Worldwide - The affected product distribution included the United States and the countries of European Union, Chile, and Hong Kong. No affected product was distributed to Canada; however, Health Canada was notified because the product is registered in Canada.

Code information

Model number: ST101UB / 08787174 190; GTIN code: 5711435000156; Lot-number: 04909125 and 04912125.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2937-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2937-2026. Report a data issue: hello@regdatalab.com.